bismuth has been researched along with Erythroblastosis Fetalis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| KAYSER, HW | 1 |
| BLAHA, J; SLUNSKY, R | 1 |
2 other study(ies) available for bismuth and Erythroblastosis Fetalis
| Article | Year |
|---|---|
Antiluetic Therapy for Erythroblastosis Prophylaxis.
Topics: Antacids; Antidiarrheals; Bismuth; Erythroblastosis, Fetal; Hematologic Diseases; Humans; Salicylates | 1955 |
[Contribution to mhe prophylaxis and therapy of hemolytic disease in the newborn].
Topics: Antacids; Bismuth; Erythroblastosis, Fetal; Fetus; Hematologic Diseases; Prednisone; Riboflavin; Vitamin E | 1962 |